Screener
Arcutis Biotherapeutics, Inc. ARQT Current Debt
Current Debt at other companies
Other financials
Where this comes from
Reported directly by Arcutis Biotherapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LongTermDebtCurrent.
The source filing: Arcutis Biotherapeutics, Inc.’s 10-Q, filed August 5, 2026. Open the filing →
- Filed
- Aug 5, 2026, 4:21 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001787306-26-000051
FAQ
- What is Arcutis Biotherapeutics, Inc.'s current debt?
- Arcutis Biotherapeutics, Inc. (ARQT) reported current debt of $6.95M in Q2 2026.
- How has Arcutis Biotherapeutics, Inc.'s current debt changed year-over-year?
- Arcutis Biotherapeutics, Inc.'s current debt increased by 595.0% year-over-year, from $1M to $6.95M.
- What does current debt mean?
- The portion of long-term debt maturing within the next 12 months, requiring refinancing or repayment from operating cash flows.
Ask your AI about Arcutis Biotherapeutics, Inc.'s current debt.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude